Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma

Oncogene

Volumn 26, Issue 44, 2007, Pages 6456-6468

  Tanaka, K ^a   Imoto, I ^a,b   Inoue, J ^a,b   Kozaki, K ^a   Tsuda, H ^b,c   Shimada, Y ^d   Aiko, S ^c   Yoshizumi, Y ^c   Iwai, T ^a   Kawano, T ^a   Inazawa, J ^a,b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^d HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

BAMCA; CRABP1; DNA methylation; Esophageal squamous cell carcinoma; Tumor suppressor

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CELLULAR RETINOIC ACID BINDING PROTEIN 1; MESSENGER RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; GENE AMPLIFICATION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MALE; METHYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

AZACITIDINE; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; DNA METHYLATION; EPIGENESIS, GENETIC; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROMOTER REGIONS (GENETICS); RECEPTORS, RETINOIC ACID; TUMOR MARKERS, BIOLOGICAL;

BACTERIA (MICROORGANISMS);

EID: 34848924607     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210459     Document Type: Article

References (43)

1. de Bruijn DR, Oerlemans F, Hendriks W, Baats E, Ploemacher R, Wieringa B et al. (1994). Normal development, growth and reproduction in cellular retinoic acid binding protein-I (CRABPI) null mutant mice. Differentiation 58: 141-148.
2. Dong D, Ruuska SE, Levinthal DJ, Noy N. (1999). Distinct roles for cellular retinoic acid-binding proteins I and II in regulating signaling by retinoic acid. J Biol Chem 274: 23695-23698.
3. Donovan M, Olofsson B, Gustafson AL, Dencker L, Eriksson U. (1995). The cellular retinoic acid binding proteins. J Steroid Biochem Mol Biol 53: 459-465.
4. Dowlatshahi K, Mehta RG, Levin B, Cerny WL, Skinner DB, Moon RC. (1984). Retinoic-acid-binding protein in normal and neoplastic human esophagus. Cancer 54: 308-311.
5. Egger G, Liang G, Aparicio A, Jones PA. (2004). Epigenetics in human disease and prospects for epigenetic therapy. Nature 429: 457-463.
6. Fiorella PD, Giguere V, Napoli JL. (1993). Expression of cellular retinoic acid-binding protein (type II) in Escherichia coli. Characterization and comparison to cellular retinoic acid-binding protein (type I). J Biol Chem 268: 21545-21552.
7. Gorry P, Lufkin T, Dierich A, Rochette-Egly C, Decimo D, Dolle P et al. (1994). The cellular retinoic acid binding protein I is dispensable. Proc Natl Acad Sci USA 91: 9032-9036.
8. Hawthorn L, Stein L, Varma R, Wiseman S, Loree T, Tan D. (2004). TIMP1 and SERPIN-A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma. Head Neck 26: 1069-1083.
9. Herman JG, Baylin SB. (2003). Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349: 2042-2054.
10. Huang Y, de la Chapelle A, Pellegata NS. (2003). Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABP1 in papillary thyroid carcinoma. Int J Cancer 104: 735-744.
11. Imoto I, Yang ZQ, Pimkhaokham A, Tsuda H, Shimada Y, Imamura M et al. (2001). Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas. Cancer Res 61: 6629-6634.
12. Inazawa J, Inoue J, Imoto I. (2004). Comparative genomic hybridization (CGH)-arrays pave the way for identification of novel cancer-related genes. Cancer Sci 95: 559-563.
13. Ito T, Shimada Y, Hashimoto Y, Kaganoi J, Kan T, Watanabe G et al. (2003). Involvement of TSLC1 in progression of esophageal squamous cell carcinoma. Cancer Res 63: 6320-6326.
14. Jones PA, Baylin SB. (2002). The fundamental role of epigenetic events in cancer. Nat Rev Genet 3: 415-428.
15. Kaifi JT, Yekebas EF, Schurr P, Obonyo D, Wachowiak R, Busch P et al. (2005). Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer. J Natl Cancer Inst 97: 1840-1847.
16. Kim MS, Yamashita K, Baek JH, Park HL, Carvalho AL, Osada M et al. (2006). N-methyl-D-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer. Cancer Res 66: 3409-3418.
17. Kuroki T, Trapasso F, Yendamuri S, Matsuyama A, Alder H, Mori M et al. (2003). Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res 63: 3724-3728.
18. Laird PW. (2003). The power and the promise of DNA methylation markers. Nat Rev Cancer 3: 253-266.
19. Mandelker DL, Yamashita K, Tokumaru Y, Mimori K, Howard DL, Tanaka Y et al. (2005). PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma. Cancer Res 65: 4963-4968.
20. Means AL, Thompson JR, Gudas LJ. (2000). Transcriptional regulation of the cellular retinoic acid binding protein I gene in F9 teratocarcinoma cells. Cell Growth Differ 11: 71-82.
21. Misawa A, Inoue J, Sugino Y, Hosoi H, Sugimoto T, Hosoda F et al. (2005). Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification. Cancer Res 65: 10233-10242.
22. Miyazaki T, Kato H, Shitara Y, Yoshikawa M, Tajima K, Masuda N et al. (2000). Mutation and expression of the metastasis suppressor gene KAI1 in esophageal squamous cell carcinoma. Cancer 89: 955-962.
23. Miyazaki T, Kato H, Fukuchi M, Nakajima M, Kuwano H. (2003). EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma. Int J Cancer 103: 657-663.
24. Ogino S, Cantor M, Kawasaki T, Brahmandam M, Kirkner G, Weisenberger DJ et al. (2006). CpG island methylator phenotype (CIMP) of colorectal cancer is best characterized by quantitative DNA methylation analysis and prospective cohort studies. Gut 55: 1000-1006.
25. Ohtsu A. (2004). Chemoradiotherapy for esophageal cancer: current status and perspectives. Int J Clin Oncol 9: 444-450.
26. Parkin DM, Bray F, Ferlay J, Pisani P. (2005). Global Cancer Statistics, 2002. CA Cancer J Clin 55: 74-108.
27. Pfoertner S, Goelden U, Hansen W, Toepfer T, Geffers R, Ukena SN et al. (2005). Cellular retinoic acid binding protein I: expression and functional influence in renal cell carcinoma. Tumour Biol 26: 313-323.
28. Pimkhaokham A, Shimada Y, Fukuda Y, Kurihara N, Imoto I, Yang ZQ et al. (2000). Nonrandom chromosomal imbalances in esophageal squamous cell carcinoma cell lines: possible involvement of the ATF3 and CENPF genes in the 1q32 amplicon. Jpn J Cancer Res 91: 1126-1133.
29. Roder JD, Busch R, Stein HJ, Fink U, Siewert JR. (1994). Ratio of invaded to removed lymph node are predictors of survival in squamous cell carcinoma of the esophagus. Br J Surg 81: 410-413.
30. Shibata H, Matsubara O, Wakiyama H, Tanaka S. (2001). The role of cyclin-dependent kinase inhibitor p27 in squamous cell carcinoma of the esophagus. Pathol Res Pract 197: 157-164.
31. Shibagaki I, Shimada Y, Wagata T, Ikenaga M, Imamura M, Ishizaki K. (1994). Allelotype analysis of esophageal squamous cell carcinoma. Cancer Res 54: 2996-3000.
32. Shimada Y, Imamura M, Wagata T, Yamaguchi N, Tobe T. (1992). Characterization of 21 newly established esophageal cancer cell lines. Cancer 69: 277-284.
33. Shirakawa Y, Naomoto Y, Kimura M, Kawashima R, Yamatsuji T, Tamaki T et al. (2000). Topological analysis of p21WAF1/CIP1 expression in esophageal squamous dysplasia. Clin Cancer Res 6: 541-550.
34. Sobin LH, Wittekind CH (ed). (2002). International Union Against Cancer (UICC): TNM Classification of Malignant Tumors 6th edn. Wiley-Liss: New York.
35. Sonoda I, Imoto I, Inoue J, Shibata T, Shimada Y, Chin K et al. (2004). Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma. Cancer Res 64: 3741-3747.
36. Stein HJ, Feith M, Bruecher BL, Naehrig J, Sarbia M, Siewert JR. (2005). Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg 242: 566-573.
37. Suzuki H, Gabrielson E, Chen W, Anbazhagan R, van Engeland M, Weijenberg MP et al. (2002). A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 31: 141-149.
38. Toyota M, Ho C, Ahuja N, Jair KW, Li Q, Ohe-Toyota M et al. (1999). Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res 59: 2307-2312.
39. Venepally P, Reddy LG, Sani BP. (1996). Characterization of cellular retinoic acid-binding protein I from chick embryo and its ligand binding properties. Arch Biochem Biophys 336: 231-239.
40. Wei LN, Chang L. (1996). Promoter and upstream regulatory activities of the mouse cellular retinoic acid-binding protein-I gene. J Biol Chem 271: 5073-5078.
41. Wei LN, Lee CH. (1994). Demethylation in the 50-flanking region of mouse cellular retinoic acid binding protein-I gene is associated with its high level of expression in mouse embryos and facilitates its induction by retinoic acid in P19 embryonal carcinoma cells. Dev Dyn 201: 1-10.
42. Xiong Z, Laird PW. (1997). COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 25: 2532-2534.
43. Yamashita K, Upadhyay S, Osada M, Hoque MO, Xiao Y, Mori M et al. (2002). Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell 2: 485-495.